UB
AUPH icon

UMB Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

UMB Bank’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-969
Closed -$10K – 1750
2022
Q2 		$10K Hold
969
– – ﹤0.01% 1383
2022
Q1 		$12K Sell
969
-77
-7% -$1.19K ﹤0.01% 1426
2021
Q4 		$24K Buy
+1,046
New +$24.8K ﹤0.01% 1213

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's AUPH Position: Q3 2022 in Review

UMB Bank sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2022, closing a stake of 969 shares — an estimated $10K sold.

UMB Bank first reported a position in AUPH in Q4 2021 and held it in 3 quarters. The position peaked at $24K in Q4 2021. 189 funds tracked by Wall St. Rank hold AUPH as of Q3 2022.

  • UMB Bank reported no remaining Aurinia Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • UMB Bank sold 969 Aurinia Pharmaceuticals shares in Q3 2022, an estimated $10K.
  • UMB Bank first reported a position in Aurinia Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • UMB Bank's Aurinia Pharmaceuticals position peaked at $24K in Q4 2021.
  • 189 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2022.

Based on UMB Bank's 13F filing for Q3 2022, filed 13 Oct 2022.